Across TCGA pan-cancer cohorts, RCC2P6 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RCC2P6 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RCC2P6 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RCC2P6 expression acts as an unfavorable survival marker, although some lineages such as UCEC and KIRC show a favorable association.
UCEC, KIRC, and READ are the cancer types where RCC2P6 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.